Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

Prevention and treatment of diabetic nephropathy.

Wittmann I, Molnár GA, Degrell P, Wagner Z, Tamaskó M, Laczy B, Brasnyó P, Wagner L, Nagy J.

Diabetes Res Clin Pract. 2005 Jun;68 Suppl1:S36-42. Epub 2005 Mar 24. Review.

PMID:
15955373
2.

Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.

Ziyadeh FN, Wolf G.

Curr Diabetes Rev. 2008 Feb;4(1):39-45. Review.

PMID:
18220694
3.

The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.

Shimoike T, Inoguchi T, Umeda F, Nawata H, Kawano K, Ochi H.

Metabolism. 2000 Aug;49(8):1030-5.

PMID:
10954022
4.

[Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].

Jakić M, Jakić M, Zibar L, Mihaljević D, Stipanić S, Teskera T.

Lijec Vjesn. 2009 Jul-Aug;131(7-8):218-25. Review. Croatian.

PMID:
19769285
5.

Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition.

Langham RG, Kelly DJ, Cox AJ, Thomson NM, Holthöfer H, Zaoui P, Pinel N, Cordonnier DJ, Gilbert RE.

Diabetologia. 2002 Nov;45(11):1572-6. Epub 2002 Sep 25.

PMID:
12436341
6.

Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study.

Remuzzi G, Macia M, Ruggenenti P.

J Am Soc Nephrol. 2006 Apr;17(4 Suppl 2):S90-7. Review.

8.

Glomerular barrier dysfunction in glomerulosclerosis- resistant Milan rats with experimental diabetes: the role of renal haemodynamics.

Pugliese G, Ricci C, Iacobini C, Menini S, Fioretto P, Ferrandi M, Giardino LA, Armelloni S, Mattinzoli D, Rastaldi MP, Pugliese F.

J Pathol. 2007 Oct;213(2):210-8. Erratum in: J Pathol. 2007 Oct;213(2):218.

PMID:
17768702
10.

Urinary excretion of podocytes in patients with diabetic nephropathy.

Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H.

Nephrol Dial Transplant. 2000 Sep;15(9):1379-83.

PMID:
10978394
11.

Diabetic nephropathy--the family physician's role.

Roett MA, Liegl S, Jabbarpour Y.

Am Fam Physician. 2012 May 1;85(9):883-9.

12.

Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy.

Lambers Heerspink HJ, Fowler MJ, Volgi J, Reutens AT, Klein I, Herskovits TA, Packham DK, Fraser IR, Schwartz SL, Abaterusso C, Lewis J; Collaborative Study Group.

Diabet Med. 2007 Nov;24(11):1290-5.

PMID:
17956455
13.

Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms' tumor-1 protein used as a podocyte marker.

Su J, Li SJ, Chen ZH, Zeng CH, Zhou H, Li LS, Liu ZH.

Diabetes Res Clin Pract. 2010 Feb;87(2):167-75. doi: 10.1016/j.diabres.2009.10.022. Epub 2009 Dec 6.

PMID:
19969384
14.

The importance of diabetic nephropathy in current nephrological practice.

Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C.

Nephrol Dial Transplant. 2003 Sep;18(9):1716-25. Review.

PMID:
12937216
15.

Role of AGEs in diabetic nephropathy.

Fukami K, Yamagishi S, Ueda S, Okuda S.

Curr Pharm Des. 2008;14(10):946-52. Review.

PMID:
18473844
16.

Kidney involvement and disease in patients with diabetes.

Chiarelli F, Trotta D, Verrotti A, Mohn A.

Panminerva Med. 2003 Mar;45(1):23-41. Review.

PMID:
12682618
17.
18.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

20.

Research into the glomerular podocyte--is it relevant to diabetic nephropathy?

White KE.

Diabet Med. 2006 Jul;23(7):715-9. Review.

PMID:
16842474

Supplemental Content

Support Center